This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Di Bonaventura, G.
Right arrow Articles by Piccolomini, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Di Bonaventura, G.
Right arrow Articles by Piccolomini, R.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, January 2004, p. 151-160, Vol. 48, No. 1
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.1.151-160.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Biofilm Formation by Stenotrophomonas maltophilia: Modulation by Quinolones, Trimethoprim-Sulfamethoxazole, and Ceftazidime

Giovanni Di Bonaventura,1,2 Ilaria Spedicato,1,2 Domenico D'Antonio,3 Iole Robuffo,4 and Raffaele Piccolomini1,2*

Dipartimento di Scienze Biomediche, Laboratorio di Microbiologia Clinica,1 Centro di Scienze dell’Invecchiamento,2 Università "G. D'Annunzio"Istituto per i Trapianti d'organo e Immunocitologia, Consiglio Nazionale delle Ricerche, Sezione di Chieti, Chieti,4 Servizio di Microbiologia Clinica, Dipartimento di Ematologia ed Oncologia, Ospedale Spirito Santo, ASL Pescara, Italy3

Received 13 January 2003/ Returned for modification 8 July 2003/ Accepted 4 October 2003

We investigated the in vitro effects of seven fluoroquinolones (ciprofloxacin, grepafloxacin, levofloxacin, moxifloxacin, norfloxacin, ofloxacin, and rufloxacin), compared to those of trimethoprim-sulfamethoxazole (SXT) and ceftazidime on total biomass and cell viability of Stenotrophomonas maltophilia biofilm. S. maltophilia attached rapidly to polystyrene, within 2 h of incubation, and then biofilm formation increased over time, reaching maximum growth at 24 h. In the presence of fluoroquinolones at one-half and one-fourth the MIC, biofilm biomass was significantly (P < 0.01) reduced to 55 to 70% and 66 to 76% of original mass, respectively. Ceftazidime and SXT did not exert any activity. Biofilm bacterial viability was significantly reduced by all antibiotics tested at one-half the MIC. At one-fourth the MIC all antibiotics, except levofloxacin, significantly reduced viability. Treatment of preformed biofilms with bactericidal concentrations (500, 100, and 50 µg/ml) of all fluoroquinolones caused, except for norfloxacin, significant reduction of biofilm biomass to 29.5 to 78.8, 64.1 to 83.6, and 70.5 to 82.8% of original mass, respectively. SXT exerted significant activity at 500 µg/ml only. Ceftazidime was completely inactive. Rufloxacin exhibited the highest activity on preformed biofilm viability, significantly decreasing viable counts by 0.6, 5.4, and 17.1% at 500, 100, and 50 µg/ml, respectively. Our results show that (i) subinhibitory (one-half and one-fourth the MIC) concentrations of fluoroquinolones inhibit adherence of S. maltophilia to polystyrene and (ii) clinically achievable concentrations (50 and 100 µg/ml) of rufloxacin are able to eradicate preformed S. maltophilia biofilm.


* Corresponding author. Mailing address: Centro Scienze dell'Invecchiamento, Lab. 27, 5° Livello, Università "G. D'Annunzio," Via dei Vestini 31, 66100 Chieti, Italy. Phone: (39) 0871 355 52 83. Fax: (39) 0871 355 52 82. E-mail: r.piccolomini{at}dsb.unich.it.


Antimicrobial Agents and Chemotherapy, January 2004, p. 151-160, Vol. 48, No. 1
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.1.151-160.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Ahmed, N. A., Petersen, F. C., Scheie, A. A. (2009). AI-2/LuxS Is Involved in Increased Biofilm Formation by Streptococcus intermedius in the Presence of Antibiotics. Antimicrob. Agents Chemother. 53: 4258-4263 [Abstract] [Full Text]  
  • Waters, V. J., Gomez, M. I., Soong, G., Amin, S., Ernst, R. K., Prince, A. (2007). Immunostimulatory Properties of the Emerging Pathogen Stenotrophomonas maltophilia. Infect. Immun. 75: 1698-1703 [Abstract] [Full Text]  
  • Di Bonaventura, G., Pompilio, A., Picciani, C., Iezzi, M., D'Antonio, D., Piccolomini, R. (2006). Biofilm Formation by the Emerging Fungal Pathogen Trichosporon asahii: Development, Architecture, and Antifungal Resistance.. Antimicrob. Agents Chemother. 50: 3269-3276 [Abstract] [Full Text]  
  • Yang, Y., Sreenivasan, P. K., Subramanyam, R., Cummins, D. (2006). Multiparameter assessments to determine the effects of sugars and antimicrobials on a polymicrobial oral biofilm.. Appl. Environ. Microbiol. 72: 6734-6742 [Abstract] [Full Text]